MINDBODY Inc (NASDAQ:MB) Director Adam L. Miller acquired 3,000 shares of the business’s stock in a transaction on Tuesday, August 14th. The stock was acquired at an average price of $35.66 per share, for a total transaction of $106,980.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Shares of NASDAQ MB traded up $0.50 during midday trading on Friday, hitting $36.25. The stock had a trading volume of 16,004 shares, compared to its average volume of 531,515. The company has a market cap of $1.72 billion, a PE ratio of -118.83 and a beta of -0.16. MINDBODY Inc has a 52 week low of $21.57 and a 52 week high of $45.50. The company has a debt-to-equity ratio of 0.86, a quick ratio of 9.61 and a current ratio of 9.61.

MINDBODY (NASDAQ:MB) last issued its earnings results on Tuesday, July 31st. The technology company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.04). The firm had revenue of $61.61 million during the quarter, compared to the consensus estimate of $60.48 million. MINDBODY had a negative return on equity of 6.83% and a negative net margin of 11.85%. analysts forecast that MINDBODY Inc will post -0.61 earnings per share for the current fiscal year.

A number of equities research analysts have weighed in on the stock. BidaskClub cut shares of MINDBODY from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 1st. Credit Suisse Group cut their price objective on shares of MINDBODY from $41.00 to $38.00 and set a “neutral” rating on the stock in a report on Wednesday, August 1st. TheStreet upgraded shares of MINDBODY from a “d+” rating to a “c” rating in a report on Monday, June 18th. JPMorgan Chase & Co. upped their price objective on shares of MINDBODY to $48.00 and gave the stock an “overweight” rating in a report on Wednesday, August 1st. They noted that the move was a valuation call. Finally, Zacks Investment Research downgraded shares of MINDBODY from a “hold” rating to a “sell” rating in a research note on Wednesday, April 25th. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. MINDBODY currently has a consensus rating of “Buy” and a consensus target price of $37.77.

Hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC bought a new position in MINDBODY during the first quarter valued at approximately $122,000. Sei Investments Co. bought a new position in MINDBODY during the first quarter valued at approximately $143,000. Nwam LLC bought a new position in MINDBODY during the second quarter valued at approximately $205,000. Granite Springs Asset Management LLC bought a new position in MINDBODY during the first quarter valued at approximately $210,000. Finally, Amalgamated Bank bought a new position in MINDBODY during the first quarter valued at approximately $223,000. Hedge funds and other institutional investors own 90.61% of the company’s stock.

MINDBODY Company Profile

MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.

Recommended Story: NASDAQ Stock Market Explained

Insider Buying and Selling by Quarter for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.